logo-loader

Rexahn Pharmaceuticals, Inc.

Receive alerts
Market:
AMEX
Market Cap:
£0.00
Price
0.00 0
Change
0%
52 weeks high
0
52 weeks low
0

In brief

Rexahn’s goal is to be a world-class biopharmaceutical company developing and delivering novel cures for cancer and disorders of the central nervous system (CNS) to patients worldwide. Leveraging a powerful, multi-faceted discovery engine consisting of small signaling molecule discovery, computational modeling and nanotechnology-based drug targeting and delivery, we believe that we are well on our way to achieving our goal.